pharmaphorum November 30, 2023
FDA chief scientist Namandjé Bumpus has been named as principal deputy commissioner, replacing long-serving Janet Woodcock when she steps down early next year.
Bumpus is heading for the number two position at the FDA – second only to Commissioner Robert Califf, who announced the appointment on X (formerly Twitter) – just over a year after she joined the agency.
“As principal deputy commissioner, Namandjé will work closely with FDA leadership to develop, advance, and implement key public health initiatives, as well as to oversee the agency’s day-to-day functions,” said Califf in an email to staff.
“Chief among those priorities is the proposed reorganisation unifying the Human Foods Programme, creating a new model for the Office of Regulatory Affairs, and strengthening...